Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 5.10720707 |
2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.99546621 |
3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.58031785 |
4 | glutamate secretion (GO:0014047) | 4.12905974 |
5 | protein localization to endosome (GO:0036010) | 3.72199688 |
6 | respiratory burst (GO:0045730) | 3.67681547 |
7 | neutrophil activation (GO:0042119) | 3.56421545 |
8 | positive regulation of mast cell activation (GO:0033005) | 3.54101818 |
9 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.52904229 |
10 | positive regulation of mast cell degranulation (GO:0043306) | 3.52904229 |
11 | granulocyte activation (GO:0036230) | 3.51980562 |
12 | phagosome maturation (GO:0090382) | 3.44972719 |
13 | sequestering of actin monomers (GO:0042989) | 3.40072237 |
14 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.37101458 |
15 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.31904745 |
16 | eosinophil chemotaxis (GO:0048245) | 3.30360423 |
17 | signal complex assembly (GO:0007172) | 3.23933243 |
18 | myeloid dendritic cell differentiation (GO:0043011) | 3.20042499 |
19 | immunoglobulin mediated immune response (GO:0016064) | 3.16224549 |
20 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.15240604 |
21 | regulation of ARF protein signal transduction (GO:0032012) | 3.09485727 |
22 | cellular response to type I interferon (GO:0071357) | 3.06118466 |
23 | type I interferon signaling pathway (GO:0060337) | 3.06118466 |
24 | response to peptidoglycan (GO:0032494) | 3.04581723 |
25 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.03500829 |
26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01154923 |
27 | response to type I interferon (GO:0034340) | 2.99328072 |
28 | myeloid dendritic cell activation (GO:0001773) | 2.98834203 |
29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96773529 |
30 | negative regulation of cell killing (GO:0031342) | 2.96773529 |
31 | leukocyte aggregation (GO:0070486) | 2.93884178 |
32 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.93681544 |
33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.91460191 |
34 | eosinophil migration (GO:0072677) | 2.91319236 |
35 | positive regulation of synapse maturation (GO:0090129) | 2.90828961 |
36 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.86130543 |
37 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.86130543 |
38 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.86037750 |
39 | regulation of early endosome to late endosome transport (GO:2000641) | 2.84873187 |
40 | positive regulation of interferon-alpha production (GO:0032727) | 2.83920809 |
41 | adenosine receptor signaling pathway (GO:0001973) | 2.83708426 |
42 | synaptic vesicle maturation (GO:0016188) | 2.83705401 |
43 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.81395104 |
44 | myeloid cell activation involved in immune response (GO:0002275) | 2.80251218 |
45 | cerebellar granule cell differentiation (GO:0021707) | 2.79969065 |
46 | layer formation in cerebral cortex (GO:0021819) | 2.79239563 |
47 | barbed-end actin filament capping (GO:0051016) | 2.78714761 |
48 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.76684203 |
49 | neurotransmitter secretion (GO:0007269) | 2.74346735 |
50 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.74078230 |
51 | positive regulation of regulated secretory pathway (GO:1903307) | 2.73449513 |
52 | leukocyte mediated cytotoxicity (GO:0001909) | 2.72798964 |
53 | response to pheromone (GO:0019236) | 2.72643855 |
54 | negative regulation of interleukin-17 production (GO:0032700) | 2.71514166 |
55 | regulation of mast cell degranulation (GO:0043304) | 2.71261102 |
56 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70813302 |
57 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.70136085 |
58 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.70134232 |
59 | activation of Rac GTPase activity (GO:0032863) | 2.69715449 |
60 | regulation of leukocyte degranulation (GO:0043300) | 2.69124597 |
61 | regulation of necrotic cell death (GO:0010939) | 2.68569651 |
62 | regulation of synaptic vesicle transport (GO:1902803) | 2.68493904 |
63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68306304 |
64 | regulation of hypersensitivity (GO:0002883) | 2.68094883 |
65 | monocyte chemotaxis (GO:0002548) | 2.67090575 |
66 | negative regulation of necrotic cell death (GO:0060547) | 2.67067247 |
67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.66121898 |
68 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.65160679 |
69 | regulation of interferon-alpha production (GO:0032647) | 2.64554312 |
70 | cellular response to zinc ion (GO:0071294) | 2.64440978 |
71 | modulation by symbiont of host immune response (GO:0052553) | 2.63144947 |
72 | positive regulation by symbiont of host defense response (GO:0052509) | 2.63144947 |
73 | modulation by symbiont of host defense response (GO:0052031) | 2.63144947 |
74 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.63144947 |
75 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.63144947 |
76 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.63144947 |
77 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.61649550 |
78 | sodium ion export (GO:0071436) | 2.60731369 |
79 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.60688441 |
80 | dendritic cell differentiation (GO:0097028) | 2.60075155 |
81 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.58192868 |
82 | positive regulation of protein dephosphorylation (GO:0035307) | 2.58169721 |
83 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.57532940 |
84 | positive regulation of macrophage differentiation (GO:0045651) | 2.56521367 |
85 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.55269868 |
86 | mast cell activation (GO:0045576) | 2.53321317 |
87 | amino acid import (GO:0043090) | 2.52811456 |
88 | detection of temperature stimulus (GO:0016048) | 2.52773992 |
89 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.51494569 |
90 | positive regulation of antigen processing and presentation (GO:0002579) | 2.51474840 |
91 | leukocyte degranulation (GO:0043299) | 2.50851193 |
92 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.50751005 |
93 | cellular potassium ion homeostasis (GO:0030007) | 2.50037565 |
94 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.49629541 |
95 | regulation of defense response to virus by virus (GO:0050690) | 2.48522169 |
96 | positive regulation of leukocyte degranulation (GO:0043302) | 2.47954198 |
97 | behavioral response to pain (GO:0048266) | 2.47778762 |
98 | L-amino acid import (GO:0043092) | 2.47096483 |
99 | positive regulation of macrophage cytokine production (GO:0060907) | 2.46737012 |
100 | regulation of regulated secretory pathway (GO:1903305) | 2.46133756 |
101 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.45993612 |
102 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.45810159 |
103 | neuronal action potential propagation (GO:0019227) | 2.45736370 |
104 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.45693640 |
105 | transferrin transport (GO:0033572) | 2.45387621 |
106 | macrophage activation involved in immune response (GO:0002281) | 2.45007735 |
107 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.44985283 |
108 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.44313237 |
109 | regulation of mast cell activation (GO:0033003) | 2.43801030 |
110 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.43689013 |
111 | synaptic vesicle exocytosis (GO:0016079) | 2.43610196 |
112 | leukocyte cell-cell adhesion (GO:0007159) | 2.42641672 |
113 | regulation of mononuclear cell migration (GO:0071675) | 2.42630397 |
114 | protein retention in ER lumen (GO:0006621) | 2.42233738 |
115 | response to muramyl dipeptide (GO:0032495) | 2.39595853 |
116 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.39524201 |
117 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.39378354 |
118 | regulation of monocyte chemotaxis (GO:0090025) | 2.37975186 |
119 | response to gravity (GO:0009629) | 2.37818717 |
120 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.37007606 |
121 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.37007606 |
122 | actin nucleation (GO:0045010) | 2.36880438 |
123 | regulation of superoxide anion generation (GO:0032928) | 2.36063854 |
124 | myeloid leukocyte mediated immunity (GO:0002444) | 2.35294574 |
125 | negative regulation of necroptotic process (GO:0060546) | 2.35131516 |
126 | regulation of beta-amyloid formation (GO:1902003) | 2.34787954 |
127 | cellular response to nicotine (GO:0071316) | 2.34391376 |
128 | myeloid leukocyte activation (GO:0002274) | 2.33293236 |
129 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.32428724 |
130 | defense response to protozoan (GO:0042832) | 2.32317909 |
131 | cellular response to interferon-gamma (GO:0071346) | 2.30739585 |
132 | regulation of RIG-I signaling pathway (GO:0039535) | 2.28766580 |
133 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.27889671 |
134 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.27736876 |
135 | regulation of synaptic plasticity (GO:0048167) | 2.27701113 |
136 | reactive oxygen species biosynthetic process (GO:1903409) | 2.27199582 |
137 | mature B cell differentiation involved in immune response (GO:0002313) | 2.25995045 |
138 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.24173633 |
139 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.23603479 |
140 | pinocytosis (GO:0006907) | 2.23391966 |
141 | protein targeting to plasma membrane (GO:0072661) | 2.22515025 |
142 | neuromuscular process controlling balance (GO:0050885) | 2.20352193 |
143 | actin filament depolymerization (GO:0030042) | 2.19846304 |
144 | positive regulation of Rap GTPase activity (GO:0032854) | 2.19747910 |
145 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.19595213 |
146 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.18644264 |
147 | response to manganese ion (GO:0010042) | 2.18092548 |
148 | negative regulation of type 2 immune response (GO:0002829) | 2.18080467 |
149 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.17426901 |
150 | cell-cell junction maintenance (GO:0045217) | 2.14973832 |
151 | negative regulation of ERBB signaling pathway (GO:1901185) | 2.14605342 |
152 | regulation of ARF GTPase activity (GO:0032312) | 2.13739435 |
153 | modulation by symbiont of host cellular process (GO:0044068) | 2.12383185 |
154 | potassium ion homeostasis (GO:0055075) | 2.11975402 |
155 | stress fiber assembly (GO:0043149) | 2.11863026 |
156 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.11399909 |
157 | regulation of synapse maturation (GO:0090128) | 2.11128947 |
158 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.10777411 |
159 | angiogenesis involved in wound healing (GO:0060055) | 2.10234840 |
160 | glycosphingolipid catabolic process (GO:0046479) | 2.09396637 |
161 | negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059) | 2.08887818 |
162 | cellular copper ion homeostasis (GO:0006878) | 2.08645101 |
163 | regulation of protein dephosphorylation (GO:0035304) | 2.08009651 |
164 | regulation of necroptotic process (GO:0060544) | 2.07704235 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.08664722 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.45455508 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.09609457 |
4 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.66821808 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.26883682 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.22595843 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.87714330 |
8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86881247 |
9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79643119 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.69909005 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.66599877 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65803171 |
13 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.63426972 |
14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.51803134 |
15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47388853 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.16989716 |
17 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.06815700 |
18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.04720356 |
19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03683127 |
20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.01451822 |
21 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.98845977 |
22 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.91126289 |
23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.86300117 |
24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80804194 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78621173 |
26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76529406 |
27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75641890 |
28 | MYC_22102868_ChIP-Seq_BL_Human | 1.75019489 |
29 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.68608175 |
30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68091413 |
31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67907837 |
32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67871841 |
33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60974551 |
34 | P68_20966046_ChIP-Seq_HELA_Human | 1.60688151 |
35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.60614036 |
36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59369796 |
37 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.57741876 |
38 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.54842984 |
39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53434190 |
40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51907853 |
41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.51709666 |
42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50813468 |
43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.50451469 |
44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46349224 |
45 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.43587603 |
46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43212472 |
47 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.42247297 |
48 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.41023010 |
49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40599802 |
50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40104604 |
51 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.39862708 |
52 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.39500333 |
53 | MYB_26560356_Chip-Seq_TH2_Human | 1.39391324 |
54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39209955 |
55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37881669 |
56 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36447704 |
57 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.36162115 |
58 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.35437986 |
59 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35344569 |
60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35135846 |
61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.35084364 |
62 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.34848645 |
63 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.34786321 |
64 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.33419978 |
65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32835293 |
66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32696992 |
67 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32530332 |
68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27915952 |
69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27696620 |
70 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.27143370 |
71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26891601 |
72 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26530268 |
73 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26155431 |
74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.25963502 |
75 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25952563 |
76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25928815 |
77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.24488355 |
78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23145119 |
79 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.21271317 |
80 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.21271317 |
81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20480380 |
82 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.20348544 |
83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20286586 |
84 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.20282511 |
85 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.20240267 |
86 | * MAF_26560356_Chip-Seq_TH2_Human | 1.20046202 |
87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17966931 |
88 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17918591 |
89 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17455000 |
90 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17158630 |
91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16039830 |
92 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14680810 |
93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13583602 |
94 | MAF_26560356_Chip-Seq_TH1_Human | 1.13487038 |
95 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12308152 |
96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12185677 |
97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12092329 |
98 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.12055101 |
99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11667110 |
100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10889068 |
101 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.10207984 |
102 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09862973 |
103 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08827235 |
104 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08446201 |
105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08243837 |
106 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08202331 |
107 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07245540 |
108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06948460 |
109 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.06779151 |
110 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06651435 |
111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06097476 |
112 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05584510 |
113 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05361036 |
114 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04607353 |
115 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.04579985 |
116 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02976427 |
117 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02854846 |
118 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.02781021 |
119 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02480976 |
120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01651502 |
121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01292972 |
122 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01167232 |
123 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01089422 |
124 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00975743 |
125 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00645279 |
126 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00454956 |
127 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99451008 |
128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98806763 |
129 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97106554 |
130 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96811355 |
131 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.96549766 |
132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96486634 |
133 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91878195 |
134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91679576 |
135 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91127757 |
136 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90084610 |
137 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.89747748 |
138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88669075 |
139 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88582310 |
140 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87467204 |
141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87140874 |
142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85594932 |
143 | * VDR_21846776_ChIP-Seq_THP-1_Human | 0.85569500 |
144 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85391410 |
145 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85246635 |
146 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84959513 |
147 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.84654073 |
148 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83864206 |
149 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78817408 |
150 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78073872 |
151 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78073872 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.71463839 |
2 | MP0004510_myositis | 3.44272410 |
3 | MP0009840_abnormal_foam_cell | 3.11857977 |
4 | MP0002148_abnormal_hypersensitivity_rea | 3.10963170 |
5 | MP0009785_altered_susceptibility_to | 3.08581689 |
6 | MP0003436_decreased_susceptibility_to | 3.06900934 |
7 | MP0004858_abnormal_nervous_system | 2.82428919 |
8 | MP0005000_abnormal_immune_tolerance | 2.50027219 |
9 | MP0005671_abnormal_response_to | 2.46571766 |
10 | MP0003724_increased_susceptibility_to | 2.46206693 |
11 | MP0005387_immune_system_phenotype | 2.36916960 |
12 | MP0001790_abnormal_immune_system | 2.36916960 |
13 | MP0002735_abnormal_chemical_nociception | 2.31048967 |
14 | MP0002419_abnormal_innate_immunity | 2.29166229 |
15 | MP0000685_abnormal_immune_system | 2.29103229 |
16 | MP0009046_muscle_twitch | 2.28692687 |
17 | MP0005025_abnormal_response_to | 2.28217418 |
18 | MP0001968_abnormal_touch/_nociception | 2.21582468 |
19 | MP0006082_CNS_inflammation | 2.17463412 |
20 | MP0004859_abnormal_synaptic_plasticity | 2.17112956 |
21 | MP0005058_abnormal_lysosome_morphology | 2.15994007 |
22 | MP0002877_abnormal_melanocyte_morpholog | 2.13494254 |
23 | MP0005451_abnormal_body_composition | 2.07991683 |
24 | MP0002452_abnormal_antigen_presenting | 1.88247391 |
25 | MP0002723_abnormal_immune_serum | 1.85957223 |
26 | MP0003172_abnormal_lysosome_physiology | 1.85775001 |
27 | MP0002736_abnormal_nociception_after | 1.82167290 |
28 | MP0001819_abnormal_immune_cell | 1.81689408 |
29 | MP0002420_abnormal_adaptive_immunity | 1.78516880 |
30 | MP0010386_abnormal_urinary_bladder | 1.76136879 |
31 | MP0005310_abnormal_salivary_gland | 1.74411801 |
32 | MP0002733_abnormal_thermal_nociception | 1.73989935 |
33 | MP0000920_abnormal_myelination | 1.72098974 |
34 | MP0003635_abnormal_synaptic_transmissio | 1.70951762 |
35 | MP0003303_peritoneal_inflammation | 1.70910088 |
36 | MP0003690_abnormal_glial_cell | 1.69990137 |
37 | MP0002405_respiratory_system_inflammati | 1.69560704 |
38 | MP0001800_abnormal_humoral_immune | 1.63898982 |
39 | MP0004782_abnormal_surfactant_physiolog | 1.63865466 |
40 | MP0000343_altered_response_to | 1.63613660 |
41 | MP0008874_decreased_physiological_sensi | 1.60758075 |
42 | MP0005167_abnormal_blood-brain_barrier | 1.58228754 |
43 | MP0001533_abnormal_skeleton_physiology | 1.53454506 |
44 | MP0001970_abnormal_pain_threshold | 1.52244584 |
45 | MP0002734_abnormal_mechanical_nocicepti | 1.52209857 |
46 | MP0006276_abnormal_autonomic_nervous | 1.52187275 |
47 | MP0008569_lethality_at_weaning | 1.45247174 |
48 | MP0003075_altered_response_to | 1.43938403 |
49 | MP0009764_decreased_sensitivity_to | 1.40161622 |
50 | MP0001845_abnormal_inflammatory_respons | 1.39887428 |
51 | MP0002064_seizures | 1.35356957 |
52 | MP0001986_abnormal_taste_sensitivity | 1.32427465 |
53 | MP0005464_abnormal_platelet_physiology | 1.30686925 |
54 | MP0003300_gastrointestinal_ulcer | 1.29535655 |
55 | MP0001501_abnormal_sleep_pattern | 1.29279088 |
56 | MP0003866_abnormal_defecation | 1.28033992 |
57 | MP0003705_abnormal_hypodermis_morpholog | 1.27089328 |
58 | MP0009278_abnormal_bone_marrow | 1.25030326 |
59 | MP0002998_abnormal_bone_remodeling | 1.24236301 |
60 | MP0004270_analgesia | 1.23643680 |
61 | MP0000716_abnormal_immune_system | 1.22159340 |
62 | MP0003448_altered_tumor_morphology | 1.21599252 |
63 | MP0001348_abnormal_lacrimal_gland | 1.21305963 |
64 | MP0005166_decreased_susceptibility_to | 1.21049781 |
65 | MP0003634_abnormal_glial_cell | 1.20690375 |
66 | MP0002184_abnormal_innervation | 1.20608142 |
67 | MP0010155_abnormal_intestine_physiology | 1.20331293 |
68 | MP0003183_abnormal_peptide_metabolism | 1.20054136 |
69 | MP0002067_abnormal_sensory_capabilities | 1.19362294 |
70 | MP0009745_abnormal_behavioral_response | 1.18526707 |
71 | MP0002272_abnormal_nervous_system | 1.16714522 |
72 | MP0002398_abnormal_bone_marrow | 1.15316268 |
73 | MP0005165_increased_susceptibility_to | 1.13491486 |
74 | MP0003880_abnormal_central_pattern | 1.13409583 |
75 | MP0000604_amyloidosis | 1.12738975 |
76 | MP0003091_abnormal_cell_migration | 1.11928656 |
77 | MP0002063_abnormal_learning/memory/cond | 1.10905311 |
78 | MP0003453_abnormal_keratinocyte_physiol | 1.07231725 |
79 | MP0000858_altered_metastatic_potential | 1.07167747 |
80 | MP0002277_abnormal_respiratory_mucosa | 1.06987628 |
81 | MP0004947_skin_inflammation | 1.06369205 |
82 | MP0001440_abnormal_grooming_behavior | 1.05669311 |
83 | MP0005423_abnormal_somatic_nervous | 1.05156922 |
84 | MP0002006_tumorigenesis | 1.04855167 |
85 | MP0003329_amyloid_beta_deposits | 1.04417528 |
86 | MP0003566_abnormal_cell_adhesion | 1.03712022 |
87 | MP0003806_abnormal_nucleotide_metabolis | 1.00819603 |
88 | MP0002572_abnormal_emotion/affect_behav | 1.00632619 |
89 | MP0004883_abnormal_blood_vessel | 0.98879077 |
90 | MP0003123_paternal_imprinting | 0.97711207 |
91 | MP0009333_abnormal_splenocyte_physiolog | 0.96719494 |
92 | MP0000465_gastrointestinal_hemorrhage | 0.95704611 |
93 | MP0002332_abnormal_exercise_endurance | 0.95671796 |
94 | MP0000681_abnormal_thyroid_gland | 0.95478706 |
95 | MP0001545_abnormal_hematopoietic_system | 0.92851584 |
96 | MP0005397_hematopoietic_system_phenotyp | 0.92851584 |
97 | MP0001502_abnormal_circadian_rhythm | 0.91869352 |
98 | MP0005535_abnormal_body_temperature | 0.91188770 |
99 | MP0002138_abnormal_hepatobiliary_system | 0.90903000 |
100 | MP0002429_abnormal_blood_cell | 0.89833750 |
101 | MP0003763_abnormal_thymus_physiology | 0.89554140 |
102 | MP0001849_ear_inflammation | 0.89057804 |
103 | MP0001853_heart_inflammation | 0.87867707 |
104 | MP0005174_abnormal_tail_pigmentation | 0.87627397 |
105 | MP0004742_abnormal_vestibular_system | 0.87552019 |
106 | MP0004811_abnormal_neuron_physiology | 0.85993743 |
107 | MP0005164_abnormal_response_to | 0.85770305 |
108 | MP0004142_abnormal_muscle_tone | 0.84821729 |
109 | MP0008469_abnormal_protein_level | 0.83850764 |
110 | MP0003828_pulmonary_edema | 0.82243273 |
111 | MP0003879_abnormal_hair_cell | 0.81914544 |
112 | MP0002638_abnormal_pupillary_reflex | 0.81743317 |
113 | MP0003633_abnormal_nervous_system | 0.81710752 |
114 | MP0002089_abnormal_postnatal_growth/wei | 0.80499921 |
115 | MP0002166_altered_tumor_susceptibility | 0.80101167 |
116 | MP0008004_abnormal_stomach_pH | 0.78772769 |
117 | MP0003631_nervous_system_phenotype | 0.78370403 |
118 | MP0005023_abnormal_wound_healing | 0.78092613 |
119 | MP0000678_abnormal_parathyroid_gland | 0.76207897 |
120 | MP0003045_fibrosis | 0.75364009 |
121 | MP0002722_abnormal_immune_system | 0.75324954 |
122 | MP0005083_abnormal_biliary_tract | 0.74859593 |
123 | MP0000689_abnormal_spleen_morphology | 0.74838708 |
124 | MP0003191_abnormal_cellular_cholesterol | 0.74443213 |
125 | MP0001958_emphysema | 0.73792913 |
126 | MP0008260_abnormal_autophagy | 0.73014478 |
127 | MP0001851_eye_inflammation | 0.70066531 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.07764571 |
2 | Recurrent abscess formation (HP:0002722) | 5.93396513 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.42140677 |
4 | Neurofibrillary tangles (HP:0002185) | 4.41636584 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.25034039 |
6 | Abnormality of macrophages (HP:0004311) | 4.14431931 |
7 | Myositis (HP:0100614) | 4.09445638 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.84954718 |
9 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.80028128 |
10 | Mediastinal lymphadenopathy (HP:0100721) | 3.78080173 |
11 | Orchitis (HP:0100796) | 3.69849118 |
12 | Cerebral inclusion bodies (HP:0100314) | 3.69727892 |
13 | Increased cerebral lipofuscin (HP:0011813) | 3.50096502 |
14 | Vacuolated lymphocytes (HP:0001922) | 3.49172221 |
15 | Increased IgM level (HP:0003496) | 3.46999525 |
16 | Progressive cerebellar ataxia (HP:0002073) | 3.41412823 |
17 | Neuronal loss in central nervous system (HP:0002529) | 3.40173051 |
18 | Interstitial pulmonary disease (HP:0006530) | 3.36832083 |
19 | Recurrent fungal infections (HP:0002841) | 3.34984252 |
20 | Gingivitis (HP:0000230) | 3.30914051 |
21 | Retrobulbar optic neuritis (HP:0100654) | 3.27624140 |
22 | Optic neuritis (HP:0100653) | 3.27624140 |
23 | Action tremor (HP:0002345) | 3.25459510 |
24 | Recurrent skin infections (HP:0001581) | 3.21157996 |
25 | Myokymia (HP:0002411) | 3.17670818 |
26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.08749890 |
27 | Visual hallucinations (HP:0002367) | 3.00844770 |
28 | Failure to thrive in infancy (HP:0001531) | 2.99539437 |
29 | Obstructive lung disease (HP:0006536) | 2.98450741 |
30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.98450741 |
31 | Autoimmune thrombocytopenia (HP:0001973) | 2.96398389 |
32 | Nuclear cataract (HP:0100018) | 2.94244225 |
33 | Amyloidosis (HP:0011034) | 2.88165851 |
34 | Upper limb amyotrophy (HP:0009129) | 2.87870462 |
35 | Distal upper limb amyotrophy (HP:0007149) | 2.87870462 |
36 | Mutism (HP:0002300) | 2.81683326 |
37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.73284176 |
38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.73284176 |
39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.73284176 |
40 | Distal lower limb amyotrophy (HP:0008944) | 2.71412166 |
41 | Disinhibition (HP:0000734) | 2.68146167 |
42 | Dysostosis multiplex (HP:0000943) | 2.64783985 |
43 | Supranuclear gaze palsy (HP:0000605) | 2.63782233 |
44 | Annular pancreas (HP:0001734) | 2.62193359 |
45 | Obstructive sleep apnea (HP:0002870) | 2.55740912 |
46 | Atonic seizures (HP:0010819) | 2.54970187 |
47 | Hypothermia (HP:0002045) | 2.54012212 |
48 | Purpura (HP:0000979) | 2.52876598 |
49 | Diminished motivation (HP:0000745) | 2.44202874 |
50 | Loss of speech (HP:0002371) | 2.43731945 |
51 | Basal ganglia calcification (HP:0002135) | 2.43239097 |
52 | Ankle clonus (HP:0011448) | 2.42042609 |
53 | Vasculitis (HP:0002633) | 2.41592360 |
54 | Pustule (HP:0200039) | 2.39727363 |
55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.38391453 |
56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.38391453 |
57 | Distal lower limb muscle weakness (HP:0009053) | 2.38091428 |
58 | Apathy (HP:0000741) | 2.37645843 |
59 | J-shaped sella turcica (HP:0002680) | 2.35855092 |
60 | Lower limb amyotrophy (HP:0007210) | 2.34803830 |
61 | Achilles tendon contracture (HP:0001771) | 2.34111246 |
62 | Stomatitis (HP:0010280) | 2.31116573 |
63 | Hypercortisolism (HP:0001578) | 2.29519081 |
64 | Spinal canal stenosis (HP:0003416) | 2.28028623 |
65 | Slow saccadic eye movements (HP:0000514) | 2.24004635 |
66 | Febrile seizures (HP:0002373) | 2.21115370 |
67 | Insomnia (HP:0100785) | 2.20283138 |
68 | Recurrent viral infections (HP:0004429) | 2.20001446 |
69 | Systemic lupus erythematosus (HP:0002725) | 2.19555030 |
70 | Petechiae (HP:0000967) | 2.19374287 |
71 | Peripheral hypomyelination (HP:0007182) | 2.18812694 |
72 | Mucopolysacchariduria (HP:0008155) | 2.18657514 |
73 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18657514 |
74 | Hemoptysis (HP:0002105) | 2.17041321 |
75 | Focal motor seizures (HP:0011153) | 2.16649363 |
76 | Rapidly progressive (HP:0003678) | 2.16129325 |
77 | Upper motor neuron abnormality (HP:0002127) | 2.14283915 |
78 | Abnormality of binocular vision (HP:0011514) | 2.12188080 |
79 | Diplopia (HP:0000651) | 2.12188080 |
80 | Neuroendocrine neoplasm (HP:0100634) | 2.11715298 |
81 | Agitation (HP:0000713) | 2.10134794 |
82 | Abnormal eating behavior (HP:0100738) | 2.09767186 |
83 | Hyperacusis (HP:0010780) | 2.09311048 |
84 | Abnormality of the Achilles tendon (HP:0005109) | 2.08507560 |
85 | Broad face (HP:0000283) | 2.07417117 |
86 | Hypergammaglobulinemia (HP:0010702) | 2.07407992 |
87 | Papilledema (HP:0001085) | 2.07383313 |
88 | Tetraplegia (HP:0002445) | 2.05963132 |
89 | Thyroiditis (HP:0100646) | 2.05623696 |
90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05187318 |
91 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05187318 |
92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05187318 |
93 | Spontaneous hematomas (HP:0007420) | 2.04247555 |
94 | Urticaria (HP:0001025) | 2.02892517 |
95 | Hepatosplenomegaly (HP:0001433) | 2.02223925 |
96 | Growth hormone excess (HP:0000845) | 2.01860758 |
97 | Dementia (HP:0000726) | 2.01498973 |
98 | Focal seizures (HP:0007359) | 2.01055527 |
99 | Cellulitis (HP:0100658) | 2.00975220 |
100 | Pulmonary infiltrates (HP:0002113) | 2.00844196 |
101 | Abnormality of the vocal cords (HP:0008777) | 2.00552529 |
102 | Severe combined immunodeficiency (HP:0004430) | 2.00149929 |
103 | Rigidity (HP:0002063) | 1.99934439 |
104 | Polyphagia (HP:0002591) | 1.99921786 |
105 | Meningitis (HP:0001287) | 1.99237310 |
106 | Absence seizures (HP:0002121) | 1.98839374 |
107 | Leukocytosis (HP:0001974) | 1.98241172 |
108 | Scanning speech (HP:0002168) | 1.97513992 |
109 | Abnormality of the nasal mucosa (HP:0000433) | 1.96879927 |
110 | Progressive inability to walk (HP:0002505) | 1.96393370 |
111 | Inappropriate behavior (HP:0000719) | 1.95270092 |
112 | Pheochromocytoma (HP:0002666) | 1.94691463 |
113 | Arterial thrombosis (HP:0004420) | 1.93314869 |
114 | Truncal ataxia (HP:0002078) | 1.92060454 |
115 | Tetraparesis (HP:0002273) | 1.91657703 |
116 | Axonal loss (HP:0003447) | 1.91460369 |
117 | Abnormal gallbladder physiology (HP:0012438) | 1.91420638 |
118 | Cholecystitis (HP:0001082) | 1.91420638 |
119 | Poor head control (HP:0002421) | 1.91185734 |
120 | Abnormal hair whorl (HP:0010721) | 1.90583001 |
121 | Periodontitis (HP:0000704) | 1.90145911 |
122 | Cerebral hemorrhage (HP:0001342) | 1.90132999 |
123 | Menstrual irregularities (HP:0000858) | 1.90129884 |
124 | Difficulty climbing stairs (HP:0003551) | 1.88623108 |
125 | Abnormality of T cell number (HP:0011839) | 1.88271247 |
126 | Prolonged neonatal jaundice (HP:0006579) | 1.87868581 |
127 | Delusions (HP:0000746) | 1.87199421 |
128 | Hyperparathyroidism (HP:0000843) | 1.84927741 |
129 | Polygenic inheritance (HP:0010982) | 1.84848937 |
130 | Depression (HP:0000716) | 1.84806636 |
131 | Cerebral aneurysm (HP:0004944) | 1.83740137 |
132 | Spastic gait (HP:0002064) | 1.83485767 |
133 | Prolonged bleeding time (HP:0003010) | 1.83195730 |
134 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.82497246 |
135 | Combined immunodeficiency (HP:0005387) | 1.82486905 |
136 | Decreased motor nerve conduction velocity (HP:0003431) | 1.81622954 |
137 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81408312 |
138 | Hand muscle atrophy (HP:0009130) | 1.81242675 |
139 | Epistaxis (HP:0000421) | 1.81181499 |
140 | Ocular albinism (HP:0001107) | 1.77971527 |
141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77850654 |
142 | Vertebral compression fractures (HP:0002953) | 1.77200357 |
143 | Increased serum ferritin (HP:0003281) | 1.76589083 |
144 | Onion bulb formation (HP:0003383) | 1.76582411 |
145 | Global brain atrophy (HP:0002283) | 1.75786118 |
146 | Distal sensory impairment (HP:0002936) | 1.75677371 |
147 | Foot dorsiflexor weakness (HP:0009027) | 1.75312750 |
148 | Hypertensive crisis (HP:0100735) | 1.74940612 |
149 | Hemiplegia (HP:0002301) | 1.73869431 |
150 | Esophageal neoplasm (HP:0100751) | 1.73513784 |
151 | Neoplasm of head and neck (HP:0012288) | 1.73513784 |
152 | Prostate neoplasm (HP:0100787) | 1.73206846 |
153 | Dysmetria (HP:0001310) | 1.73201258 |
154 | Hemorrhage of the eye (HP:0011885) | 1.72498398 |
155 | Psychosis (HP:0000709) | 1.70719184 |
156 | Horizontal nystagmus (HP:0000666) | 1.70460959 |
157 | Increased connective tissue (HP:0009025) | 1.70444109 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K12 | 5.03858115 |
2 | RIPK4 | 3.57124461 |
3 | ARAF | 3.24066650 |
4 | IRAK3 | 3.15417227 |
5 | MAP3K14 | 2.67842808 |
6 | NME2 | 2.53746719 |
7 | CAMKK2 | 2.44793856 |
8 | PIM2 | 2.42351916 |
9 | TESK2 | 2.26425539 |
10 | TBK1 | 2.22693197 |
11 | TRIB3 | 2.14979911 |
12 | MAP3K9 | 2.08040407 |
13 | MAP3K13 | 2.07717260 |
14 | KSR2 | 1.99567607 |
15 | EPHA2 | 1.97743497 |
16 | LMTK2 | 1.85800429 |
17 | TAOK2 | 1.81981021 |
18 | IRAK4 | 1.79790343 |
19 | BLK | 1.76048464 |
20 | RIPK1 | 1.72665695 |
21 | MATK | 1.72602778 |
22 | ERBB3 | 1.72126817 |
23 | EPHA4 | 1.70433670 |
24 | SIK3 | 1.69827328 |
25 | MINK1 | 1.67490851 |
26 | JAK3 | 1.61673689 |
27 | TYK2 | 1.60584583 |
28 | MAP4K1 | 1.60579389 |
29 | ZAP70 | 1.58207833 |
30 | IKBKE | 1.55251985 |
31 | TXK | 1.48261241 |
32 | MST1R | 1.46817638 |
33 | KIT | 1.39284437 |
34 | SIK1 | 1.38342868 |
35 | CAMKK1 | 1.33241208 |
36 | ICK | 1.31696957 |
37 | NTRK1 | 1.31211851 |
38 | ERN1 | 1.29988790 |
39 | MAP3K3 | 1.29168109 |
40 | DAPK2 | 1.27673977 |
41 | NTRK3 | 1.27604432 |
42 | BMPR2 | 1.25639028 |
43 | MAP3K11 | 1.21943564 |
44 | NEK9 | 1.17372767 |
45 | SCYL2 | 1.17098477 |
46 | DAPK1 | 1.11944931 |
47 | TESK1 | 1.11259283 |
48 | GRK5 | 1.10507089 |
49 | JAK1 | 1.08946069 |
50 | EPHB1 | 1.08204587 |
51 | LIMK1 | 1.04876284 |
52 | PRKD3 | 1.04388315 |
53 | MAP3K1 | 1.02582170 |
54 | PDPK1 | 1.01381709 |
55 | IRAK2 | 1.01322755 |
56 | MARK2 | 0.99228737 |
57 | STK38 | 0.98458048 |
58 | SYK | 0.96697866 |
59 | IKBKB | 0.96455633 |
60 | MAP3K2 | 0.96146079 |
61 | RAF1 | 0.95980994 |
62 | MYLK | 0.95737659 |
63 | PRKD2 | 0.95402716 |
64 | CSK | 0.95018245 |
65 | ADRBK2 | 0.94293432 |
66 | BTK | 0.91499303 |
67 | TAOK1 | 0.89557686 |
68 | RPS6KA2 | 0.86624893 |
69 | MST4 | 0.85988399 |
70 | RET | 0.83661211 |
71 | PRKCH | 0.83376787 |
72 | GRK7 | 0.82181031 |
73 | PDK1 | 0.81490911 |
74 | MOS | 0.81070806 |
75 | PTK6 | 0.79975246 |
76 | MAPK12 | 0.79860021 |
77 | LCK | 0.75207484 |
78 | PAK4 | 0.74884565 |
79 | TEC | 0.73137545 |
80 | TTN | 0.72409653 |
81 | PTK2 | 0.72024676 |
82 | BRAF | 0.71561266 |
83 | FES | 0.71542011 |
84 | MAP2K4 | 0.71417864 |
85 | ITK | 0.70563701 |
86 | BMX | 0.70308801 |
87 | JAK2 | 0.70293900 |
88 | TGFBR2 | 0.69631755 |
89 | PAK6 | 0.69521994 |
90 | CDK19 | 0.69200698 |
91 | HCK | 0.68941389 |
92 | GRK6 | 0.68633016 |
93 | SMG1 | 0.66114441 |
94 | PRKG2 | 0.65212926 |
95 | CHUK | 0.65022500 |
96 | CDK15 | 0.62820421 |
97 | CDK14 | 0.62800542 |
98 | PRPF4B | 0.62557784 |
99 | MAP2K7 | 0.62312414 |
100 | NTRK2 | 0.60995830 |
101 | ABL2 | 0.60695045 |
102 | CDK11A | 0.59832994 |
103 | LATS2 | 0.59755920 |
104 | CDK18 | 0.59234607 |
105 | UHMK1 | 0.59025676 |
106 | DAPK3 | 0.58832924 |
107 | CAMK2B | 0.58031508 |
108 | BCR | 0.57899690 |
109 | TNK2 | 0.57553479 |
110 | MAP3K5 | 0.56238889 |
111 | CAMK2G | 0.55658159 |
112 | YES1 | 0.55307846 |
113 | CDC42BPA | 0.54250090 |
114 | PRKCD | 0.54183612 |
115 | PLK2 | 0.52062513 |
116 | CDK5 | 0.51011700 |
117 | PHKG1 | 0.50673790 |
118 | PHKG2 | 0.50673790 |
119 | KSR1 | 0.50127862 |
120 | FGR | 0.49659957 |
121 | RPS6KA6 | 0.49327142 |
122 | ERBB4 | 0.49216573 |
123 | BCKDK | 0.49176723 |
124 | ILK | 0.48116042 |
125 | MAPK11 | 0.45216747 |
126 | MAP2K6 | 0.44844262 |
127 | MAP2K1 | 0.44700140 |
128 | HIPK2 | 0.44595445 |
129 | FYN | 0.44465460 |
130 | PAK1 | 0.43480544 |
131 | LRRK2 | 0.42860999 |
132 | ADRBK1 | 0.42414734 |
133 | MET | 0.41765665 |
134 | FGFR3 | 0.41490301 |
135 | DYRK1B | 0.41339513 |
136 | SIK2 | 0.41230422 |
137 | CAMK1 | 0.41082668 |
138 | CSF1R | 0.40740023 |
139 | RPS6KL1 | 0.40699603 |
140 | RPS6KC1 | 0.40699603 |
141 | PIM1 | 0.40532607 |
142 | WNK1 | 0.40468435 |
143 | KDR | 0.40252915 |
144 | MAP2K3 | 0.40168635 |
145 | LYN | 0.39176469 |
146 | MARK3 | 0.38383473 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.48809078 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16847409 |
3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.00213977 |
4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.91322559 |
5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.90783772 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77670503 |
7 | Phagosome_Homo sapiens_hsa04145 | 1.62857310 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59691962 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 1.56715590 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53654478 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53391328 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.52236106 |
13 | Lysosome_Homo sapiens_hsa04142 | 1.51016877 |
14 | Pertussis_Homo sapiens_hsa05133 | 1.46277863 |
15 | Salmonella infection_Homo sapiens_hsa05132 | 1.44532169 |
16 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.44526029 |
17 | Shigellosis_Homo sapiens_hsa05131 | 1.41330066 |
18 | Allograft rejection_Homo sapiens_hsa05330 | 1.41123185 |
19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39343388 |
20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38238349 |
21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.37368371 |
22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.36483516 |
23 | Prion diseases_Homo sapiens_hsa05020 | 1.28808096 |
24 | Long-term depression_Homo sapiens_hsa04730 | 1.25735281 |
25 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23896457 |
26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.23206356 |
27 | Legionellosis_Homo sapiens_hsa05134 | 1.22471961 |
28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.22027747 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21661048 |
30 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.19195208 |
31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15609183 |
32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15030482 |
33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13309529 |
34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12029265 |
35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10896523 |
36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.10703757 |
37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10191270 |
38 | Measles_Homo sapiens_hsa05162 | 1.09592877 |
39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.08447814 |
40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08356157 |
41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07593432 |
42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07483432 |
43 | Influenza A_Homo sapiens_hsa05164 | 1.06749862 |
44 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06591824 |
45 | Circadian entrainment_Homo sapiens_hsa04713 | 1.06159464 |
46 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.05749628 |
47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04945221 |
48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04582772 |
49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04162663 |
50 | Morphine addiction_Homo sapiens_hsa05032 | 1.04113359 |
51 | Asthma_Homo sapiens_hsa05310 | 1.03882654 |
52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03366402 |
53 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02546884 |
54 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.01936977 |
55 | Apoptosis_Homo sapiens_hsa04210 | 1.01610675 |
56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01128949 |
57 | Malaria_Homo sapiens_hsa05144 | 1.00913590 |
58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00913314 |
59 | Taste transduction_Homo sapiens_hsa04742 | 1.00046353 |
60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98629340 |
61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98408754 |
62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95271671 |
63 | Glioma_Homo sapiens_hsa05214 | 0.93336956 |
64 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.92360878 |
65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91677367 |
66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91124390 |
67 | Salivary secretion_Homo sapiens_hsa04970 | 0.90296261 |
68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89645396 |
69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.89409619 |
70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88326574 |
71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88293816 |
72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87156533 |
73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85163201 |
74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84685242 |
75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84308569 |
76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83479786 |
77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83232693 |
78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82984182 |
79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81985907 |
80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80792847 |
81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79689611 |
82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78284482 |
83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76759493 |
84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75539435 |
85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74745135 |
86 | Bladder cancer_Homo sapiens_hsa05219 | 0.74070895 |
87 | Platelet activation_Homo sapiens_hsa04611 | 0.73885375 |
88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73125794 |
89 | Endocytosis_Homo sapiens_hsa04144 | 0.72926479 |
90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71796925 |
91 | Hepatitis B_Homo sapiens_hsa05161 | 0.71648622 |
92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71588637 |
93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70899773 |
94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70129286 |
95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69790349 |
96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69301334 |
97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69272619 |
98 | Renin secretion_Homo sapiens_hsa04924 | 0.68927997 |
99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68571037 |
100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66365804 |
101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.66176006 |
102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66092023 |
103 | Hepatitis C_Homo sapiens_hsa05160 | 0.66025763 |
104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65741807 |
105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65726085 |
106 | Amoebiasis_Homo sapiens_hsa05146 | 0.65607575 |
107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65474332 |
108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65307710 |
109 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65064466 |
110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64729892 |
111 | Insulin secretion_Homo sapiens_hsa04911 | 0.64632437 |
112 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60614270 |
113 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60556448 |
114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59963131 |
115 | Gap junction_Homo sapiens_hsa04540 | 0.59625492 |
116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59567116 |
117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59238032 |
118 | Mineral absorption_Homo sapiens_hsa04978 | 0.59070501 |
119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58599768 |
120 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58155480 |
121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57457209 |
122 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56354064 |
123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55731939 |
124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55470342 |
125 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54946147 |
126 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.54717031 |
127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53880542 |